Corbus Pharmaceuticals Holding (CRBP)
$11.25
$-0.03
(-0.27%)
As on 02-Sep-2026 14:36EDT
Market cap
$211 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
2.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0.2
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-6.5
-
Face value
--
-
Shares outstanding
19,341,293
10 Years Aggregate
CFO
$-345.68 Mln
EBITDA
$-449.95 Mln
Net Profit
$-445.93 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Corbus Pharmaceuticals Holding (CRBP)
| 38.2 | 25.4 | 45.2 | 20.1 | 19.2 | -21.6 | -21.5 |
|
BSE Sensex
| -9.6 | -2.0 | 3.1 | -4.7 | 5.4 | 6.0 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Corbus Pharmaceuticals Holding (CRBP)
| -31.0 | 94.3 | 82.2 | -82.0 | -50.7 | -77.1 | -6.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Corbus Pharmaceuticals Holding (CRBP)
|
11.3 | 211.0 | 0.0 | -101.9 | -- | -81.6 | -- | 2.1 |
| 84.3 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 265.6 | 16,261.1 | 1,054.4 | 755.9 | 5.7 | -- | 19 | 9.8 | |
| 71.2 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 58.4 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 109.2 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 366.5 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 543.3 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 592.3 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 357.4 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 |
Shareholding Pattern
View DetailsAbout Corbus Pharmaceuticals Holding (CRBP)
Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to... release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts. Read more
-
CEO & Director
Dr. Yuval Cohen Ph.D.
-
CEO & Director
Dr. Yuval Cohen Ph.D.
-
Headquarters
Norwood, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Corbus Pharmaceuticals Holding (CRBP)
What is the current share price of Corbus Pharmaceuticals Holding (CRBP) Today?
The share price of Corbus Pharmaceuticals Holding (CRBP) is $11.25 (NASDAQ) as of 02-Sep-2026 14:36 EDT. Corbus Pharmaceuticals Holding (CRBP) has given a return of 19.15% in the last 3 years.
What is the current PB & PE ratio of Corbus Pharmaceuticals Holding (CRBP)?
Since, TTM earnings of Corbus Pharmaceuticals Holding (CRBP) is negative, P/E ratio is not available.
The P/B ratio of Corbus Pharmaceuticals Holding (CRBP) is 2.11 times as on 28-Aug-2026, a 59 discount to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-1.38 |
0.73 |
2024 |
-3.57 |
1.01 |
2023 |
-0.60 |
-3.87 |
2022 |
-0.01 |
0.01 |
2021 |
-0.06 |
0.04 |
What is the 52 Week High and Low of Corbus Pharmaceuticals Holding (CRBP)?
The 52-week high and low of Corbus Pharmaceuticals Holding (CRBP) are Rs 20.56 and Rs 7.12 as of 03-Sep-2026.
What is the market cap of Corbus Pharmaceuticals Holding (CRBP)?
Corbus Pharmaceuticals Holding (CRBP) has a market capitalisation of $ 211 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Corbus Pharmaceuticals Holding (CRBP)?
Before investing in Corbus Pharmaceuticals Holding (CRBP), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.